Moxley, a Pioneer in Muscular Dystrophy Research and Care, to Step Down
Richard (Dick) Moxley III, M.D., one of the founding fathers of the URMC Department of Neurology and an important member of the CTSI community, is retiring after a career spanning more than four decades. Moxley, who holds the Helen Aresty Fine and Irving Fine Professorship in Neurology, is widely recognized for helping revolutionize our understanding of muscular dystrophy and the care of patients with this disease.
Upon his arrival in Rochester, Moxley helped start a Muscular Dystrophy Association-funded program focused on Duchenne muscular dystrophy, a childhood disease found primarily in boys. He was later part of a team that established the National Registry for Myotonic Dystrophy and Facioscapulohumeral Dystrophy, two of the most common forms of muscular dystrophy in adults, which now includes more than 2,200 people with these conditions.
The national registry has been an invaluable research tool that has enabled researchers across the county to study these diseases and recruit participants for clinical trials. In 2002, Moxley and his research partner, Charles Thornton, M.D., were the first to discover how a genetic flaw in individuals with the myotonic dystrophy (DM) interferes with important functions in muscle and other cells with help from the registry.
Moxley has also been a passionate advocate of patient-centered care, collaborating with former CTSI